Journal list menu
Export Citations
Download PDFs
Table of Contents
Open Access
oa
Nutritional considerations with antiobesity medications
- First Published: 10 June 2024
Open Access
oa
GLP1Ra-based therapies and DXA-acquired musculoskeletal health outcomes: a focused meta-analysis of placebo-controlled trials
- First Published: 22 December 2024
Open Access
oa
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5
- First Published: 18 January 2023
Open Access
oa
Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence
- First Published: 30 March 2023
Open Access
oa
Reducing BMI below the obesity threshold in adolescents treated with once-weekly subcutaneous semaglutide 2.4 mg
- First Published: 17 May 2023
Open Access
oa
Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery
- First Published: 05 November 2023
Open Access
oa
Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis
- First Published: 21 November 2023
Open Access
oa
Physiology of the weight-loss plateau in response to diet restriction, GLP-1 receptor agonism, and bariatric surgery
- First Published: 22 April 2024
Open Access
oa
Efficacy and safety of semaglutide 2.4 mg by race and ethnicity: A post hoc analysis of three randomized controlled trials
- First Published: 27 June 2024
Open Access
oa
Weight maintenance on cost-effective antiobesity medications after 1 year of GLP-1 receptor agonist therapy: a real-world study
- First Published: 18 November 2024
Open Access
oa
Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials
- First Published: 05 January 2025
Open Access
oa
Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial
- First Published: 13 February 2025